June 1, 2026 Rezolve Ai Positioned at the Heart of the AI Transformation of $30 Trillion Global Retail, Reiterates $360M+ FY26 Revenue Guidance
June 1, 2026 Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026